Ann: BARD1 Awarded BTB Funding to Develop Breast Cancer Test, page-17

I think the company should come out and spell out what exactly is the plan going forward.
On the face of it it would appear that the SubB2M, from now on will be known as Sub, is more accurate than BD1's test.
I think the interesting thing will be if they can run both together in the one blood test.
I'm sure like most companies they are wishing they stayed in Perth and didn't decide to move to Melbourne as I doubt anything has actually happened in the last 8 months and looks likely to continue unless comrade Dan can be reigned in.
I think all time lines the company had have probably now slipped by 12 months minimum.
I also don't like paying a dozen people to do sfa.
I think Irminger-Finger might have asked for a pay rise to roll over on the SDX deal.
her pay has gone from 150k to 275k and Hinch collected a ~8.5% pay increase also up from 361k to 392k.
For a company with very little income our wages bill has gone from 699K in 2019 to 1.2 million in 2020.
Nice work if you can get it.